| EPB244 | Drug resistance in children with HIV in the Democratic Republic of Congo, Equatorial Guinea and Panama | E-poster | Resistance to ART |
| EPB245 | High drug resistance levels compromise the control of HIV infection in paediatric and adult populations in Bata, Equatorial Guinea | E-poster | Resistance to ART |
| EPB246 | High-level of cross-resistance to 2nd generation non-nucleoside reverse transcriptase inhibitors among patients failing antiretroviral therapy in Cameroon: implications for future ART-regimens in Africa | E-poster | Resistance to ART |
| EPB247 | Evaluation of HIV drug resistance in virally suppressed patients in Cameroon | E-poster | Resistance to ART |
| EPB248 | High levels of non-nucleoside reverse transcriptase inhibitor (NNRTI) pre-treatment HIV drug resistance (PDR) in Zambia: results from the national survey | E-poster | Resistance to ART |
| EPB249 | Combined effects of the K156N integrase polymorphism and 3'PPT resistance mutations against integrase inhibitors | E-poster | Resistance to ART |
| EPB250 | Profiling integrase mutations after raltegravir salvage therapy failure in Brazil | E-poster | Resistance to ART |
| EPB251 | Virological failure and acquired drug resistance among ART-experienced people living with HIV in Nepal: a nationally representative surveillance study | E-poster | Resistance to ART |
| EPB252 | Impact of Dolutegravir (DTG) on viral load suppression and HIV Drug Resistance (HIVDR) among Zambian children on ART: Results from the pediatric Acquired HIVDR (pADR) national survey | E-poster | Resistance to ART |
| EPB253 | High levels of Acquired HIV Drug Resistance (ADR) among HIV positive Zambian adults with HIV treatment failure: results from the national ADR survey | E-poster | Resistance to ART |